We are an iconic provider of hospital-based healthcare, striving to deliver an exceptional standard of care
We comprise several hospitals, health centres, a nationally accredited education provider and a world-class research institute
We are a nationally accredited, hospital-based Registered Training Organisation - the only one of its kind in Queensland
We are part of a collaborative research institute with The University of Queensland and founding partner of the Translational Research Institute
Health . Education . Research . Foundation
Researchers from Mater Research are pioneering a new approach to symptom relief by trialling medicinal cannabis in advanced cancer patients.
February is Ovarian Cancer Awareness Month held to educate people on the disease as it is still one of the deadliest women’s cancers. Every day in Australia, four ...
February is Ovarian Cancer Awareness Month held to educate people on the disease as it is still one of the deadliest women’s cancer. Every day in Australia, four ...
Mater Researcher Associate Professor Kristen Radford has been awarded a 2020 Fulbright Future Scholarship allowing her to progress her cancer research with a four ...
Collaboration between clinical research institutes the Griffith Institute for Drug Discovery (GRIDD), Mater Research and Translational Research Institute (TRI) has ...
Mater Researcher Dr Felicity Davis has been awarded one of two $50,000 Metcalf Prizes from the National Stem Cell Foundation of Australia
Mater Research CEO Professor Maher Gandhi has been appointed to a new National Blood Cancer Taskforce to deliver Australia’s first National Strategic Action Plan for ...
Mater Research CEO and MRI-UQ Director Professor Maher Gandhi and his team report that immune-infiltration is a promising tool to improve outcomes for patients with ...
More Australians living with follicular lymphoma could benefit from tailored treatment through development of a new clinical scoring model thanks to Mater Research.
A Mater researcher has developed a method to predict breast cancer patient responses to a commonly prescribed breast cancer drug.
Mater researcher Professor Geoff Faulkner and his lab have published a paper that explores the development of resistance to chemotherapy in ovarian cancer. Each year ...
During the month of May Mater commemorates Bladder Cancer Awareness Month to raise awareness for the disease which is the ninth most common cancer worldwide.